Liver Cancer Trial, Recruiting (NCT06621472)

Liver Cancer Trial, Recruiting NCT06621472 Sponsor: Cairo University Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06621472 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People whose overall physical health before surgery is rated as either "ASA II" (mild systemic disease) or "ASA III" (serious systemic disease) — a classification assigned by an anaesthesiologist (confirm with trial site)
People with a Body Mass Index (BMI) between 20 and 35 kg/m²

Who may not be able to join:

People who do not wish to participate
People whose pre-surgery health is rated as "ASA IV" (severe, life-threatening systemic disease) by an anaesthesiologist
People with a BMI below 20 or above 35 kg/m²
People with a known allergy, sensitivity, or medical reason to avoid the study medications, which include local anaesthetics and opioid pain relievers
People with a history of psychological disorders and/or chronic pain
People for whom nerve-blocking anaesthesia techniques are not safe, such as those with a local skin infection, pre-existing nerve damage, or blood clotting problems
People with severe heart, breathing, or kidney disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: sayed M Abed, Cairo University

Phone: 1226806532

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06621472

Sponsor: Cairo University

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: 1226806532

More information: https://clinicaltrials.gov/study/NCT06621472

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People whose overall physical health before surgery is rated as either "ASA II" (mild systemic disease) or "ASA III" (serious systemic disease) — a classification assigned by an anaesthesiologist (confirm with trial site)
People with a Body Mass Index (BMI) between 20 and 35 kg/m²

Who may not be able to join:

People who do not wish to participate
People whose pre-surgery health is rated as "ASA IV" (severe, life-threatening systemic disease) by an anaesthesiologist
People with a BMI below 20 or above 35 kg/m²
People with a known allergy, sensitivity, or medical reason to avoid the study medications, which include local anaesthetics and opioid pain relievers
People with a history of psychological disorders and/or chronic pain
People for whom nerve-blocking anaesthesia techniques are not safe, such as those with a local skin infection, pre-existing nerve damage, or blood clotting problems
People with severe heart, breathing, or kidney disease

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Cairo University

Registry

ClinicalTrials.gov

Start date

1 October 2024

Est. completion

1 May 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

post-operative analgesic consumption for 24 hours among study groups.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov